Publisher
Springer Science and Business Media LLC
Reference56 articles.
1. Motola-Kuba, D., Zamora-Valdes, D., Uribe, M. & Mendez-Sanchez, N. Hepatocellular carcinoma. An overview. Annals of hepatology 5, 16–24 (2006).
2. Omar, H. A. et al. Targeting of the Akt-nuclear factor-kappa B signaling network by [1-(4-chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol (OSU-A9), a novel indole-3-carbinol derivative, in a mouse model of hepatocellular carcinoma. Molecular pharmacology 76, 957–968 (2009).
3. McGlynn, K. A. & London, W. T. The global epidemiology of hepatocellular carcinoma: present and future. Clin Liver Dis 15, 223–243, vii–x (2011).
4. Tabrizian, P., Jibara, G., Shrager, B., Schwartz, M. & Roayaie, S. Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. Ann Surg 261, 947–955 (2015).
5. Omar, H. A. et al. Antitumor effects of OSU-2S, a nonimmunosuppressive analogue of FTY720, in hepatocellular carcinoma. Hepatology 53, 1943–1958 (2011).
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献